Two Sigma Investments
RCUS icon

Two Sigma Investments’s Arcus Biosciences RCUS Stock Holding History

Two Sigma Investments’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.75M Buy
312,690
+173,059
+124% +$3.74M 0.01% 1730
2025
Q4 		$3.33M Sell
139,631
-331,891
-70% -$6.77M ﹤0.01% 2071
2025
Q3 		$6.41M Buy
471,522
+63,327
+16% +$658K 0.01% 1268
2025
Q2 		$3.32M Buy
408,195
+109,771
+37% +$938K 0.01% 1503
2025
Q1 		$2.34M Buy
298,424
+151,738
+103% +$1.76M 0.01% 1635
2024
Q4 		$2.18M Buy
146,686
+11,027
+8% +$180K ﹤0.01% 1649
2024
Q3 		$2.07M Buy
135,659
+30,531
+29% +$481K ﹤0.01% 1660
2024
Q2 		$1.6M Sell
105,128
-158,149
-60% -$2.55M ﹤0.01% 1700
2024
Q1 		$4.97M Buy
263,277
+150,204
+133% +$2.6M 0.01% 975
2023
Q4 		$2.16M Buy
113,073
+70,858
+168% +$1.13M 0.01% 1477
2023
Q3 		$758K Buy
+42,215
New +$848K ﹤0.01% 2082
2022
Q4 		– Sell
-49,891
Closed -$1.3M – 3028
2022
Q3 		$1.3M Buy
+49,891
New +$1.32M ﹤0.01% 1350
2022
Q1 		– Sell
-160,336
Closed -$6.49M – 4025
2021
Q4 		$6.49M Buy
160,336
+91,891
+134% +$3.56M 0.01% 1042
2021
Q3 		$2.39M Sell
68,445
-69,307
-50% -$2.16M 0.01% 1821
2021
Q2 		$3.78M Buy
137,752
+103,883
+307% +$2.97M 0.01% 1376
2021
Q1 		$951K Sell
33,869
-170,364
-83% -$5.93M ﹤0.01% 2374
2020
Q4 		$5.3M Sell
204,233
-387,713
-65% -$9.38M 0.02% 899
2020
Q3 		$10.1M Buy
591,946
+224,628
+61% +$5.02M 0.04% 503
2020
Q2 		$9.09M Buy
367,318
+313,047
+577% +$8.45M 0.05% 421
2020
Q1 		$753K Sell
54,271
-70,702
-57% -$879K 0.01% 1638
2019
Q4 		$1.26M Buy
124,973
+92,123
+280% +$775K ﹤0.01% 1976
2019
Q3 		$299K Sell
32,850
-11,033
-25% -$88.7K ﹤0.01% 2968
2019
Q2 		$349K Buy
+43,883
New +$439K ﹤0.01% 2769

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Two Sigma Investments's RCUS Position: Q1 2026 in Review

Two Sigma Investments increased its Arcus Biosciences (RCUS) stake by 124% in Q1 2026, buying an estimated $3.74M and bringing the position to 312,690 shares worth $6.75M. The position accounts for 0.01% of the portfolio, ranked #1730.

Two Sigma Investments first reported a position in RCUS in Q2 2019 and has held it in 23 quarters since. The position peaked at $10.1M in Q3 2020. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Two Sigma Investments held 312,690 shares of Arcus Biosciences worth $6.75M as of Q1 2026.
  • Two Sigma Investments bought 173,059 Arcus Biosciences shares in Q1 2026, an estimated $3.74M.
  • Arcus Biosciences made up 0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1730 holding.
  • Two Sigma Investments first reported a position in Arcus Biosciences in Q2 2019 and has held it in 23 quarters since.
  • Two Sigma Investments's Arcus Biosciences position peaked at $10.1M in Q3 2020.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.